CHRU de Montpellier, Hopital Gui de Chauliac

Montpellier 34295

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Relapsing-remitting Multiple Sclerosis, Spinal Muscular Atrophy

Studies at this site

• A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy — Completed